Study findings suggested that assessing ctDNA levels was as good or better at predicting recurrence than experimental tests ...

BillionToOne, a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, announced today that its comprehensive genomic profiling assay Northstar ...

The global bioanalytical testing services market was worth USD 2.7 billion in 2020 and is further projected to reach USD 6.1 billion by 2027, at a CAGR of 12.1% during the forecast period (2021-2027).

It is well known that men are reluctant to see a doctor, especially a urologist. As a result, there is a risk that prostate ...

The US Food and Drug Administration granted clearances for testing instruments, a blood clot drug companion diagnostic test, and infectious disease tests, among other devices.

A bioreactor that mimics a circulatory system can deliver nutrients and oxygen to artificial tissue, enabling the production ...

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.

A multidisciplinary clinical team led by Professor Bernat Soria from the Institute of Bioengineering at the Miguel Hernández University of Elche (UMH, Spain) has developed a new method to deliver cell ...

Vitamin D deficiency directly causes erectile dysfunction by increasing superoxide and reducing protective SLPI levels, as ...

The advent of digital droplet PCR (ddPCR) has marked a paradigm shift in molecular diagnostics, offering unparalleled sensitivity, precision, and reproducibility. Within the domain of forensic science ...

New laser-based technology detects and chemically identifies nanoplastics in human fluids. Findings raise concern over ...